These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 9382555)

  • 21. Risk factors for liver metastases after curative surgical procedures for gastric cancer: a prospective study of 208 patients treated with surgical resection.
    Marrelli D; Roviello F; De Stefano A; Fotia G; Giliberto C; Garosi L; Pinto E
    J Am Coll Surg; 2004 Jan; 198(1):51-8. PubMed ID: 14698311
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Arginase as a marker of cancerogenesis. III. Comparison of arginase activity with CEA and Ca 19-9 in liver metastases of colorectal cancer].
    Porembska Z; Skwarek A; Chrzanowska A; Mielczarek M; Nyckowski P; Barańczyk-Kuźma A
    Pol Merkur Lekarski; 2004 Jan; 16(91):31-3. PubMed ID: 15074017
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum human hepatocyte growth factor (hHGF) is elevated in patients with metastatic gastric carcinoma.
    Niki M; Isozaki H; Toyoda M; Ishibashi T; Fujii K; Nomura E; Mabuchi H; Nakamura M; Nishiguchi K; Tanigawa N
    Hepatogastroenterology; 1999; 46(25):568-73. PubMed ID: 10228863
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Study of intraarteric infusion chemotherapy with drug delivery system].
    Takahashi Y; Suga T; Ohta T; Sawaguchi K; Ogino T; Mai M
    Gan To Kagaku Ryoho; 1990 Aug; 17(8 Pt 2):1754-7. PubMed ID: 2117902
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combined measurement of hepatocyte growth factor and carcinoembryonic antigen as a prognostic marker for patients with dukes a and B colorectal cancer: results of a five-year study.
    Miki C; Inoue Y; Hiro J; Ojima E; Araki T; Uchida K; Kusunoki M
    Dis Colon Rectum; 2006 Nov; 49(11):1710-8. PubMed ID: 16990975
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biphasic changes in serum hepatocyte growth factor after transarterial chemoembolization therapy for hepato-cellular carcinoma.
    Yamazaki H; Oi H; Matsumoto K; Matsushita M; Ozeki S; Teshima T; Murayama S; Inoue T; Nakamura T; Inoue T
    Cytokine; 1996 Feb; 8(2):178-82. PubMed ID: 8777277
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum hepatocyte growth factor as a marker of tumor activity in head and neck squamous cell carcinoma.
    Kim CH; Lee JS; Kang SO; Bae JH; Hong SP; Kahng H
    Oral Oncol; 2007 Nov; 43(10):1021-5. PubMed ID: 17306605
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reg IV is a serum biomarker for gastric cancer patients and predicts response to 5-fluorouracil-based chemotherapy.
    Mitani Y; Oue N; Matsumura S; Yoshida K; Noguchi T; Ito M; Tanaka S; Kuniyasu H; Kamata N; Yasui W
    Oncogene; 2007 Jun; 26(30):4383-93. PubMed ID: 17237819
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effects of chemotherapy on circulating angiogenic factor levels in patients with breast cancer].
    Tang JH; Zhao JH; Gong JP; Qin JW; Pan LQ; Xu ZY
    Zhonghua Zhong Liu Za Zhi; 2007 Mar; 29(3):210-4. PubMed ID: 17649639
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preoperative serum carcinoembryonic antigen level as a predictive factor of recurrence after curative resection of colorectal cancer.
    Takagawa R; Fujii S; Ohta M; Nagano Y; Kunisaki C; Yamagishi S; Osada S; Ichikawa Y; Shimada H
    Ann Surg Oncol; 2008 Dec; 15(12):3433-9. PubMed ID: 18846401
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of serum CA72-4, CEA, TPA, CA19-9 and CA125 levels in gastric cancer patients and correlation with recurrence.
    Lai IR; Lee WJ; Huang MT; Lin HH
    Hepatogastroenterology; 2002; 49(46):1157-60. PubMed ID: 12143226
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A comparison of tumour M2-PK with carcinoembryonic antigen and CA19-9 in patients undergoing liver resection for colorectal metastases.
    Kumar Y; Pinedo IR; Tapuria N; Zabron A; Davidson BR
    Eur J Gastroenterol Hepatol; 2008 Oct; 20(10):1006-11. PubMed ID: 18787469
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Effects and problems of intraarterial noradrenaline-induced hypertensive chemotherapy for liver metastasis of gastric cancer].
    Arai K; Kitamura M; Iwasaki Y
    Gan To Kagaku Ryoho; 1994 Sep; 21(13):2132-5. PubMed ID: 7944421
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Changes in tumor markers CEA, Ca 19-9 and Ca 125 in monitoring of response to chemotherapy in elderly patients with advanced gastric cancer].
    Caponetti R; Caponetti T; Vici P
    Clin Ter; 2002; 153(6):373-5. PubMed ID: 12645392
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum hepatocyte growth factor level associate with gastric cancer progression.
    Wu CW; Chi CW; Su TL; Liu TY; Lui WY; P'eng FK
    Anticancer Res; 1998; 18(5B):3657-9. PubMed ID: 9854473
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Prognostic study of preoperative serum levels of CEA and CA 19-9 in colorectal cancer].
    Uehara M; Manaka D; Baba S; Oji Y; Hirata K; Shimizu M; Noguchi M
    Gan To Kagaku Ryoho; 2007 Sep; 34(9):1413-7. PubMed ID: 17876139
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [mRNA expression of basic fibroblast growth factor and hepatocyte growth factor in gastric carcinoma and significance thereof].
    Ru GQ; Zhao ZS; Tang QL; Xu WJ
    Zhonghua Yi Xue Za Zhi; 2008 Jul; 88(29):2030-5. PubMed ID: 19080429
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Dose intensity and clinical response in patients with advanced gastric carcinoma treated by induced hypertension chemotherapy].
    Sato H; Urushiyama M; Sugiyama K; Ishizuka K; Hoshi M; Wakui A
    Gan To Kagaku Ryoho; 1990 Mar; 17(3 Pt 2):564-9. PubMed ID: 2321982
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of interleukin-6, interleukin-10 and human hepatocyte growth factor as tumor markers for hepatocellular carcinoma.
    Hsia CY; Huo TI; Chiang SY; Lu MF; Sun CL; Wu JC; Lee PC; Chi CW; Lui WY; Lee SD
    Eur J Surg Oncol; 2007 Mar; 33(2):208-12. PubMed ID: 17140760
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum CEA as a predictor for the response to preoperative chemoradiation in rectal cancer.
    Park YA; Sohn SK; Seong J; Baik SH; Lee KY; Kim NK; Cho CW
    J Surg Oncol; 2006 Feb; 93(2):145-50. PubMed ID: 16425302
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.